Log in

HedgePath Pharmaceuticals SEC Filings & 10K Form (OTCMKTS:HPPI)

Today's Range N/A
50-Day Range
$0.01
MA: $0.08
$0.09
52-Week Range N/A
Volume2,257 shs
Average Volume2,232 shs
Market Capitalization$18.63 million
P/E RatioN/A
Dividend YieldN/A
Beta-1.16

SEC Filings

HedgePath Pharmaceuticals (OTCMKTS:HPPI) SEC Filings

DateFilerForm TypeView
12/05/2019
4:10 PM
HedgePath Pharmaceuticals (Filer)
Form DEF 14C
12/02/2019
7:57 PM
Hasara Garrison J. (Reporting)
HedgePath Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2019
3:34 PM
HedgePath Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2019
5:56 PM
HedgePath Pharmaceuticals (Issuer)
Peattie Debra (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/31/2019
4:03 PM
HedgePath Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2019
3:30 PM
HedgePath Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2019
3:31 PM
HedgePath Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2019
3:31 PM
HedgePath Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/17/2019
4:00 PM
HedgePath Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2019
3:33 PM
HedgePath Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2019
4:00 PM
HedgePath Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2019
5:27 PM
HedgePath Pharmaceuticals (Issuer)
Watson W. Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
4:01 PM
HedgePath Pharmaceuticals (Filer)
Form PRE 14C
05/09/2019
8:04 AM
HedgePath Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2019
11:15 PM
HedgePath Pharmaceuticals (Filer)
Form EFFECT
04/26/2019
3:34 PM
HedgePath Pharmaceuticals (Filer)
Form POS AM
04/15/2019
4:30 PM
HedgePath Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2019
9:48 AM
HedgePath Pharmaceuticals (Filer)
Form CT ORDER
03/07/2019
8:01 AM
HedgePath Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/05/2019
6:57 PM
HedgePath Pharmaceuticals (Issuer)
Ono Richard Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
6:57 PM
HedgePath Pharmaceuticals (Issuer)
Martin Robert Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
6:54 PM
HedgePath Pharmaceuticals (Issuer)
Watson W. Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
6:52 PM
HedgePath Pharmaceuticals (Issuer)
MAGRAB E. BRENDAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
6:49 PM
HedgePath Pharmaceuticals (Issuer)
Mayne Pharma Group Ltd (Reporting)
Mayne Pharma International Pty Ltd (Reporting)
Mayne Pharma Ventures Pty Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
4:16 PM
HedgePath Pharmaceuticals (Filer)
Form DEF 14C
12/31/2018
4:16 PM
HedgePath Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2018
4:21 PM
HedgePath Pharmaceuticals (Filer)
Form PRE 14C
12/26/2018
4:15 PM
HedgePath Pharmaceuticals (Issuer)
Martin Robert Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2018
4:15 PM
HedgePath Pharmaceuticals (Issuer)
MAGRAB E. BRENDAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
7:31 AM
HedgePath Pharmaceuticals (Filer)
Form DEF 14C
12/19/2018
5:09 AM
HedgePath Pharmaceuticals (Issuer)
Mayne Pharma Group Ltd (Reporting)
Mayne Pharma International Pty Ltd (Reporting)
Mayne Pharma Ventures Pty Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2018
5:07 AM
HedgePath Pharmaceuticals (Subject)
Mayne Pharma Ventures Pty Ltd (Filed by)
Form SC 13D/A
12/17/2018
4:15 PM
HedgePath Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2018
8:02 AM
HedgePath Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2018
3:49 PM
HedgePath Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2018
3:31 PM
HedgePath Pharmaceuticals (Subject)
Mayne Pharma Ventures Pty Ltd (Filed by)
Form SC 13D/A
08/31/2018
3:30 PM
Hasara Garrison J. (Reporting)
HedgePath Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2018
8:02 AM
HedgePath Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/10/2018
3:31 PM
HedgePath Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/06/2018
4:11 PM
HedgePath Pharmaceuticals (Issuer)
Mayne Pharma Group Ltd (Reporting)
Mayne Pharma International Pty Ltd (Reporting)
Mayne Pharma Ventures Pty Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2018
4:11 PM
HedgePath Pharmaceuticals (Subject)
Mayne Pharma Ventures Pty Ltd (Filed by)
Form SC 13D/A
05/01/2018
7:31 AM
HedgePath Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/17/2018
11:15 PM
HedgePath Pharmaceuticals (Filer)
Form EFFECT
04/04/2018
3:32 PM
HedgePath Pharmaceuticals (Filer)
Form POS AM
03/15/2018
7:15 PM
HedgePath Pharmaceuticals (Issuer)
Martin Robert Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2018
5:39 PM
HedgePath Pharmaceuticals (Issuer)
MAGRAB E. BRENDAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2018
4:07 PM
HedgePath Pharmaceuticals (Issuer)
Ono Richard Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2018
4:01 PM
HedgePath Pharmaceuticals (Issuer)
Watson W. Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2018
4:00 PM
Hasara Garrison J. (Reporting)
HedgePath Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2018
4:00 PM
HedgePath Pharmaceuticals (Issuer)
VIRCA NICHOLAS J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2018
7:02 AM
HedgePath Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2018
7:00 PM
Cross Stefan (Reporting)
HedgePath Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2018
6:47 PM
HedgePath Pharmaceuticals (Issuer)
Mayne Pharma Group Ltd (Reporting)
Mayne Pharma International Pty Ltd (Reporting)
Mayne Pharma Ventures Pty Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2018
11:02 AM
HedgePath Pharmaceuticals (Filer)
Form CT ORDER
01/11/2018
8:21 AM
HedgePath Pharmaceuticals (Issuer)
Mayne Pharma Group Ltd (Reporting)
Mayne Pharma International Pty Ltd (Reporting)
Mayne Pharma Ventures Pty Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2018
8:19 AM
HedgePath Pharmaceuticals (Subject)
Mayne Pharma Ventures Pty Ltd (Filed by)
Form SC 13D/A
01/11/2018
8:01 AM
HedgePath Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2017
3:11 PM
HedgePath Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 12/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel